Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Healthcare Nova May 2016

Log in to access your May 2016 Healthcare Nova issue. Lots of really interesting news. Plus the Top 50 players across Emerging Markets, a look at the problems healthcare insurers face in Asia and will ICHOM succeed in standardising outcome measurements?

Healthcare Europa May 2016

Log in to access your May 2016 edition of Healthcare Europa. Our in-depth report on the likely impacts of the Hospital Structure Act in Germany, an interview with Eduard Maták, partner at Penta Investments - and will ICHOM succeed in standardising outcome measurements?

SAR ready to sell?

Private equity owners Palamon and GSquare have approached investment bank PJT Partners to sell Spain's largest care group, SARquavitae. Our sources note that SAR had to cancel its board meeting last week and that PJT hasn't been hired "yet". But what price will it fetch?

Aster DM expands hospital and pharmacy networks

UAE-based Aster DM is to open two 100-bed hospitals in the emirates of Sharjah and Dubai over the next three months –as part of $100m investment. Each hospital cost between $40m (AED150m) to $54m (AED200m). The group is also planning to build four other hospitals in the next two years.

Indian lab chain Dr. Lal grows

Indian lab chain Dr. Lal Pathlabs is acquiring Delta RIA and Pathology Lab in Bhopal, Central India. Dr. Lal's IPO in December 2015 subscribed 33 times, raising Rs 190 crore (US$30m). Year-on-year sales in the first quarter of 2016 grew 15% to Rs 1977 crore (US$310m), with 26% EBITDA margin.

Ping An Doctor app to bridge payer-provider gap in China

One year after its launch, Chinese insurer Ping An’s comprehensive ‘Doctor’ app raised $500m in a series A funding round. The app allows its users to access real-time consultations and health management services –becoming the most popular platform in a saturated digital market. We look at Ping An’s strategy to bridge the payer-provider gap.

Private insurers in East Asia: Between a rock and a hard place

Private medical insurers face colossal problems in China, India and across South East Asia. At this month’s Asia Healthcare Summit in Singapore, they were better at describing the challenges of culture, fraud and overtreatment than they were at coming up with solutions.

Ozzy GenesisCare rolls into Spain

Private equity house Nazca Capital has sold Spanish oncology group IMOncology to Australian radiotherapy group GenesisCare for an undisclosed amount. GenesisCare has already bought in Ireland and the UK. We spoke to Nazca.

Huge mental health treatment gap in China and India

The Lancet has reported that third of the global burden of disease for mental, neurological and substance use disorders occurs in India and China – more than in all high-income countries combined – yet 10% or less of people with mental disorders in these countries receive the needed treatment. Even for serious psychotic illness only 40% of Chinese had treatment from healthcare professionals. Both countries are about to engulfed by dementia as their populations age.

Find Us